<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03287648</url>
  </required_header>
  <id_info>
    <org_study_id>0004/2017</org_study_id>
    <nct_id>NCT03287648</nct_id>
  </id_info>
  <brief_title>Simultaneous OCT and B-FAF in Eyes With Alteration of the Foveal Contour</brief_title>
  <official_title>Simultaneous Spectral-domain Optical Coherence Tomography and Blue-fundus Autofluorescence in Eyes With Alteration of the Foveal Contour</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Molise</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Molise</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Some alterations of the foveal contour do not meet the criteria established for the&#xD;
      definition of lamellar macular hole on the basis of optical coherence tomography (OCT).&#xD;
      However, these alterations may show an appearance, on blue fundus autofluorescence (B-FAF)&#xD;
      imaging, reminiscent of lamellar macular hole.&#xD;
&#xD;
      The aim of the study is to evaluate in detail these alterations recording simultaneously OCT&#xD;
      and B-FAF.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All images will be collected using the Heidelberg Spectralis system (Heidelberg Engineering,&#xD;
      Heidelberg, Germany) according to the prespecified imaging protocols. Blue-fundus&#xD;
      autofluorescence (excitation wavelength at 488 nm and barrier filter at 500 nm) images and&#xD;
      SD-OCT images will be obtained after pupil dilation.&#xD;
&#xD;
      The OCT recording protocol will consist of a sequence of 37 horizontal sections, spaced&#xD;
      120-µm apart, covering an area of 20° or 30° horizontally by 15° vertically, and a sequence&#xD;
      of 24 radial sections recorded in the high-resolution (HR) mode simultaneously with infrared&#xD;
      (IR) images.&#xD;
&#xD;
      In addition, simultaneous B-FAF/OCT images will be acquired (horizontal, and vertical OCT&#xD;
      sections, centered on the fovea and recorded in the HR mode).&#xD;
&#xD;
      The same OCT/FAF protocol will be used for the study eye and for the fellow eye.&#xD;
&#xD;
      For the study eyes that had been examined in the past, the ''Follow-up'' function will be&#xD;
      used in addition to the prespecified protocol to evaluate if any changes had occurred since&#xD;
      the last scan.&#xD;
&#xD;
      Multiple other morphological characteristics will be analyzed using OCT imaging, including&#xD;
      the status of the posterior cortex, the presence of operculum, the integrity/disruption of&#xD;
      the external limiting membrane (ELM), ellipsoid zone (EZ), and the central and minimal foveal&#xD;
      thickness (CFT and mFT respectively). The latter will be defined as the thinnest part of the&#xD;
      fovea within the foveal pit identified by examining radial scans whereas the former will be&#xD;
      measured in relation to the highest point of the foveal bulge.&#xD;
&#xD;
      All measurements will be performed using the Spectralis built-in manual caliper function at&#xD;
      high magnification after adjusting the scale to 1:1 µm except for CFT, which will be&#xD;
      calculated using the automated ''thickness map'' function of the Heidelberg Eye Explorer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">May 20, 2024</completion_date>
  <primary_completion_date type="Actual">January 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship between OCT and B-FAF findings</measure>
    <time_frame>6 months</time_frame>
    <description>Measurements of the diameters of the holes expressed in microns, on OCT and B-FAF images respectively, will be collected. The topographic correlation between the area of increased B-FAF signal and the corresponding area on OCT, will be examined.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship between OCT and B-FAF characteristics and logMAR visual acuity</measure>
    <time_frame>6 months</time_frame>
    <description>The relationship between central foveal thickness and logMAR visual acuity will be evaluated</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Lamellar Macular Hole</condition>
  <condition>Lamellar Macular Pseudohole</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>optical coherence tomography and blue-fundus autofluorescence</intervention_name>
    <description>Simultaneous infra-red and optical coherence tomography (cube and radial pattern) centered on the fovea Simultaneous fundus autofluorescence and optical coherence tomography (radial pattern) centered on the fovea</description>
    <other_name>infra-red, color pictures</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        outpatients affected by alteration of the foveal contour associated with increased&#xD;
        autofluorescence signal at the fovea&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  alteration of the foveal contour not classifiable as lamellar or pseudo macular hole&#xD;
&#xD;
          -  focal, well-defined increased autofluorescence signal at the fovea&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  intraretinal cysts not associated with break of the inner retina&#xD;
&#xD;
          -  juxtafoveal telangiectasia&#xD;
&#xD;
          -  ring of increased B-FAF&#xD;
&#xD;
          -  vitelliform and pseudovitelliform lesions&#xD;
&#xD;
          -  history of diabetes, retinal vein occlusion, uveitis, CSR, AMD or any other retinal&#xD;
             -disease potentially associated with intra or subretinal fluid&#xD;
&#xD;
          -  macular drusen&#xD;
&#xD;
          -  history of submacular hemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Roberto dell'Omo, Prof</last_name>
    <phone>00393317120416</phone>
    <email>roberto.dellomo@unimol.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ciro Costagliola, Prof</last_name>
    <phone>00393683589790</phone>
    <email>ciro.costagliola@unimol.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Molise</name>
      <address>
        <city>Campobasso</city>
        <zip>86100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto dell'Omo, Prof</last_name>
      <phone>00393317120416</phone>
      <email>roberto.dellomo@unimol.it</email>
    </contact>
    <contact_backup>
      <last_name>Ciro Costagliola, Prof</last_name>
      <phone>00393683589790</phone>
      <email>ciro.costagliola@unimol.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 14, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2017</study_first_posted>
  <last_update_submitted>January 16, 2021</last_update_submitted>
  <last_update_submitted_qc>January 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Molise</investigator_affiliation>
    <investigator_full_name>Roberto dell'Omo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>optical coherence tomography</keyword>
  <keyword>blue fundus autofluorescence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

